Valion Bio (VBIO) Revenue (2021 - 2026)
Valion Bio (VBIO) posted quarterly Revenue of $80000.0 for Q4 2025, down 55.56% year-over-year from $180000.0 in Q4 2024, and down 45.21% quarter-over-quarter from $146000.0 in Q3 2025.
Valion Bio (VBIO) Revenue (2021 - 2026) Analysis & Trends
Valion Bio's Revenue history runs 5 years deep, the most recent figure standing at $80000.0 for Q4 2025.
- In Q4 2025, Revenue fell 55.56% year-over-year to $80000.0; the TTM figure through Dec 2025 stood at $382000.0 (down 51.03% YoY), while the FY2025 annual figure was $382000.0, down 51.03% from the prior year.
- Revenue for Q4 2025 stood at $80000.0, down from $146000.0 in the prior quarter.
- The five-year high for Revenue was $528000.0 in Q2 2022, with the low at $70000.0 in Q1 2025.
- The 5-year median for Revenue is $279500.0 (2021), against an average of $271800.0.
- The sharpest annual moves came in 2022 and 2025: Revenue jumped 97.01% in 2022, then sank 79.04% in 2025.
- Valion Bio's Revenue stood at $389000.0 in 2021, then increased by 4.88% to $408000.0 in 2022, then retreated by 12.5% to $357000.0 in 2023, then plunged by 49.58% to $180000.0 in 2024, then slumped by 55.56% to $80000.0 in 2025.
- Business Quant data shows VBIO's Revenue at $80000.0 in Q4 2025, $146000.0 in Q3 2025, and $86000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Valion Bio | 420,133.64 | -1.78 Mn | -45,000.00 | 39,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Sep 30, 2025 | 146,000.00 |
| Jun 30, 2025 | 86,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Dec 31, 2024 | 180,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 140,000.00 |
| Mar 31, 2024 | 334,000.00 |
| Dec 31, 2023 | 357,000.00 |
| Sep 30, 2023 | 282,000.00 |
| Jun 30, 2023 | 161,000.00 |
| Mar 31, 2023 | 376,000.00 |
| Dec 31, 2022 | 408,000.00 |
| Sep 30, 2022 | 477,000.00 |
| Jun 30, 2022 | 528,000.00 |
| Mar 31, 2022 | 428,000.00 |
| Dec 31, 2021 | 389,000.00 |
| Sep 30, 2021 | 277,000.00 |
| Jun 30, 2021 | 268,000.00 |